Article
Endocrinology & Metabolism
Hafeez Shaka, Maria Aguilera, Maria Aucar, Zain El-Amir, Farah Wani, Chukwudi Charles Muojieje, Asim Kichloo
Summary: This study analyzed the 2018 Nationwide Readmission Database to describe rates and characteristics of nonelective 30-day readmission among adult patients with T1DM hospitalized for DKA, as well as identify predictors of readmission. The study found a high readmission rate for DKA in T1DM patients, with most patients having DKA as the principal diagnosis on readmission. Predictors of readmission included a Charlson Comorbidity Index (CCI) score of 3 or greater, hypertension, female sex, and being discharged against medical advice.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2021)
Article
Endocrinology & Metabolism
Hafeez Shaka, Maria Aguilera, Maria Aucar, Zain El-Amir, Farah Wani, Chukwudi Charles Muojieje, Asim Kichloo
Summary: This study found a high 30-day readmission rate for patients with Type 1 diabetes hospitalized for DKA, with female sex, a Charlson Comorbidity Index of 3 or greater, and discharge against medical advice being significant predictors of readmission.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
(2021)
Article
Medicine, General & Internal
Abbas Alshami, Tiffany Purewal, Steven Douedi, Mohammed Alazzawi, Mohammad A. Hossain, Raquel Ong, Shuvendu Sen, Jennifer Cheng, Swapnil Patel
Summary: This study utilized the HCUP-NIS database in 2017 to show that compared to insulin injections, insulin pump use did not predict a lower incidence of DKA in hospitalized patients in the United States.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Endocrinology & Metabolism
Charlotte Loh, Paul Weihe, Nicole Kuplin, Kerstin Placzek, Susann Weihrauch-Blueher
Summary: The study analyzed the impact of the COVID-19 lockdown on children with diabetes mellitus, showing that the lockdown resulted in younger age and more severe DKA symptoms in children with new-onset diabetes, leading to longer hospital stays.
METABOLISM-CLINICAL AND EXPERIMENTAL
(2021)
Article
Cardiac & Cardiovascular Systems
Huan Chen, Yochai Birnbaum, Regina Ye, Hsiu-Chiung Yang, Mandeep Bajaj, Yumei Ye
Summary: SGLT2 inhibitors increase plasma ketone concentrations and may induce ketoacidosis in diabetes patients. Dehydration can precipitate SGLT2 inhibitor-induced ketoacidosis in type-2 diabetes. Dapagliflozin attenuated the development of ketoacidosis and associated signaling pathways in T1DM mice.
CARDIOVASCULAR DRUGS AND THERAPY
(2022)
Article
Endocrinology & Metabolism
Elizabeth T. Jensen, Jeanette M. Stafford, Sharon Saydah, Ralph B. D'Agostino, Lawrence M. Dolan, Jean M. Lawrence, Santica Marcovina, Elizabeth J. Mayer-Davis, Catherine Pihoker, Arleta Rewers, Dana Dabelea
Summary: The prevalence of DKA at or near type 1 diabetes diagnosis has increased from 2010 to 2016, with a 2% annual increase. This increase does not seem to be attributed to changes in sociodemographic factors over time.
Article
Multidisciplinary Sciences
William H. Hoffman, Stephen A. Whelan, Norman Lee
Summary: Diabetic ketoacidosis (DKA) is a serious complication of Type 1 diabetes (T1D) caused by insulin deficiency and insulin resistance. The metabolic and immunologic dysregulation in DKA leads to oxidative stress, inflammation, and the development of brain edema (BE). Changes in the tryptophan (TRP)/kynurenine pathway (KP) metabolites may play a role in the pathogenesis of DKA/BE.
Article
Endocrinology & Metabolism
Junlin Qiu, Xia Li, Wen Chen, Xiaoxi Ma, Zhiguo Xie, Gan Huang, Shuoming Luo, Zhiguang Zhou
Summary: The study found that the fulminant index (FI), specifically the ratio of K+ to HbA1c (K+/HbA1c), was the most effective indicator for distinguishing FT1D from initial DKA patients.
DIABETES-METABOLISM RESEARCH AND REVIEWS
(2022)
Article
Endocrinology & Metabolism
Yee Lin Lee, Fatin Farihah Wan Ahmad Nasir, Nalini M. Selveindran, Azriyanti Anuar Zaini, Poi Giok Lim, Muhammad Yazid Jalaludin
Summary: The aim of this study was to investigate the frequency, demographics, and clinical characteristics of new onset type 1 diabetes during the pandemic in Malaysia. The study found an increase in the frequency of type 1 diabetes during the pandemic, with a higher proportion of patients presenting with severe diabetic ketoacidosis.
DIABETES RESEARCH AND CLINICAL PRACTICE
(2023)
Article
Chemistry, Medicinal
Mahmoud Elshal, Marwa E. Abdelmageed
Summary: The study demonstrates that diacerein can prevent or reverse acetaminophen-induced hepatotoxicity in mice, indicating its potential clinical utility as a repurposed drug.
ARCHIVES OF PHARMACAL RESEARCH
(2022)
Article
Endocrinology & Metabolism
Yunsoo Choe, Yun Jeong Lee, Jae Hyun Kim, Kyunghoon Lee, Choong Ho Shin, Young Ah Lee, Junghan Song
Summary: It was found that T1DM patients had lower total 25OHD levels but higher free 25OHD levels. Patients with DKA had significantly lower bioavailable 25OHD levels at diagnosis.
FRONTIERS IN ENDOCRINOLOGY
(2022)
Article
Medicine, Research & Experimental
Ayman A. Al Hayek, Mohamed A. Al Dawish
Summary: Diabetic ketoacidosis (DKA) is a serious complication of poorly managed diabetes, but can be prevented with appropriate management. The study found that the use of FreeStyle Libre in patients with type 1 diabetes mellitus (T1DM) reduced the frequency and severity of DKA events, improved glycemic control, and increased the frequency of blood glucose monitoring.
ADVANCES IN THERAPY
(2021)
Article
Nutrition & Dietetics
Chung-Jen Chiang, Bruce Chi-Kang Tsai, Tzu-Li Lu, Yun-Peng Chao, Cecilia Hsuan Day, Tsung-Jung Ho, Pin-Ning Wang, Sheng-Chuan Lin, V. Vijaya Padma, Wei-Wen Kuo, Chih-Yang Huang
Summary: The findings suggest that GMNL-263 inhibits diabetes-induced cardiomyocytes by suppressing the TLR4 pathway, leading to a reduction in cardiac inflammation and fibrosis. Treatment with high-dose GMNL-263 could serve as a preventative therapy for diabetes-induced cardiomyopathy.
EUROPEAN JOURNAL OF NUTRITION
(2021)
Article
Endocrinology & Metabolism
Nicole K. Gibbings, Paul A. Kurdyak, Patricia A. Colton, Baiju R. Shah
Summary: Adolescents and young adults with type 1 diabetes and eating disorders have more than triple the risk of DKA and nearly sixfold increased risk of death compared with their peers without eating disorders.
Article
Chemistry, Medicinal
Mahmoud Elshal, Marwa E. Abdelmageed
Summary: The current study aimed to repurpose the anti-arthritic drug diacerein (DCN) for the treatment of acetaminophen-induced hepatotoxicity and investigate the underlying mechanisms. The results showed that DCN significantly reduced liver dysfunction, oxidative stress, hepatocyte necrosis, and inflammation, and inhibited acetaminophen-induced hepatocellular apoptosis. These effects were comparable to the existing treatment drug NAC.
ARCHIVES OF PHARMACAL RESEARCH
(2022)